HTT and Huntington disease: Although loss of function mechanisms almost certainly play some role in the pathophysiology of HD,32 the concept of the mutant protein having gain‐of‐function toxic properties has underpinned the current predominant therapeutic strategy of huntingtin lowering; aiming to reduce the burden of toxic huntingtin protein.